A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Purpose

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.

Conditions

  • Nonalcoholic Fatty Liver
  • Nonalcoholic Steatohepatitis

Eligibility

Eligible Ages
Over 2 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider.

Exclusion Criteria

  1. Inability to provide informed assent/consent.

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Other

Recruiting Locations

Medstar Georgetown Transplant Institute
Washington, District of Columbia 20007
Contact:
Coleman Smith, MD
202-444-0183
coleman.i.smith@gunet.georgetown.edu

More Details

Status
Recruiting
Sponsor
Target PharmaSolutions, Inc.

Study Contact

Stephanie Harrison, MPH
919-930-2792
sharrison@targetrwe.com